The Rwandan pharmaceuticals dosage market saw a steady increase in value from 2013 to 2023, standing at $386.43 million in 2023. Between 2013 and 2023, the market experienced volatility, highlighted by fluctuations such as the 29.36% increase in 2014 and a decline of 6.71% in 2022. Over five years, the market showcased a low compound annual growth rate (CAGR) of 1.91%, indicating a period of moderate growth with occasional setbacks.
Future trends to watch for include:
- The expansion of healthcare infrastructure in Rwanda, potentially boosting pharmaceutical demand.
- Impact of policy changes aimed at increasing domestic pharmaceutical production.
- The adoption of innovative health solutions and digital health platforms driving product diversification.
| # | 59 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 110,040,000,000 | 2023 | -0.57% | +2.9% | View data |
| 2 | 2 Japan | 102,270,000,000 | 2023 | +1.29% | +1.27% | View data |
| 3 | 3 Italy | 90,420,000,000 | 2023 | -0.45% | +3.03% | View data |
| 4 | 4 France | 70,241,000,000 | 2023 | -2.11% | -1.64% | View data |
| 5 | 5 United Kingdom | 69,574,000,000 | 2023 | -0.43% | -2.13% | View data |
| 52 | 52 Armenia | 414,610,000 | 2023 | +2.13% | +1.18% | View data |
| 53 | 53 Madagascar | 391,190,000 | 2023 | +3.01% | +2.84% | View data |
| 54 | 54 Rwanda | 386,430,000 | 2023 | +2.51% | +1.91% | |
| 55 | 55 Togo | 278,590,000 | 2023 | +1.78% | +2.01% | View data |
| 56 | 56 Burundi | 226,340,000 | 2023 | +1.15% | +1.86% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
